https://www.selleckchem.com/pr....oducts/pexidartinib-
3657, 95% CI 7.2655 to 51.6177, P=.0001). The risk was increased in both ****es. The RR in the male group was 23.8 (P=.0015, 95% CI) and in the female group 9.34 (P=.0001, 95% CI 3.0110to29.0121). The age distribution in the OPC group was significantly different from the age distribution in the HPV-vaccinated group (P=.0418) by Mann-Whitney test. 4376 non-vaccinated patients have developed OPC. The present study showed that HPV-vaccinated group had a reduced prevalence of OPC compared with the non-vaccinated group. The prese
Synes godt om
Kommentar
Del
